Dr. James M. Szymanski is a highly skilled and dedicated pathologist at Montefiore Medical Center in Bronx, New York, with over 15 years of experience. Dr. Szymanski excels as the Director of Apheresis and Associate Director of Transfusion Medicine. He is board-certified in Clinical Pathology, Transfusion Medicine and Blood Banking, and Clinical Informatics. Dr. Szymanski is deeply committed to advancing patient care through immunohematology and clinical apheresis....
University of Florida College of Medicine Jacksonville2009
Doctor of Medicine
Wayne State University School of Medicine2008
Master of Healthcare Administration
University of Michigan2003
Bachelor of General Studies in Biology and Public Health
University of Michigan2001
Fellowship in a Medical Specialty
National Institutes of Health
Board Certification in Clinical Pathology
American Board of Pathology
Board Certification in Blood Banking/Transfusion Medicine
American Board of Pathology
Board Certification in Clinical Informatics
American Board of Pathology
NY State Medical License
New York State Education Department – Board for Medicine
MD State Medical License
Maryland Board of Physicians
Publications:
Risk Estimation of Severe COVID-19 Based on Initial Biomarker Assessment Across Racial and Ethnic Groups.
By Caixia Bi, Ann E Salm, James Szymanski, D Yitzchak Goldstein, Lucia R Wolgast, Gregory Rosenblatt, Amy S Fox, Hema Kapoor, Martin H Kroll01-10-2023
Apheresis Illustrated. Hyper-triglyceridemic acute pancreatitis: A milky situation.
By Kevin Kuan, James Szymanski, Jamal Carter, Ronald Walsh, Monika Paroder01-12-2022
Mysterious clumping in a cell therapy product.
By Randin Nelson, Richard Mathews, Carlo Palesi, Jamal Carter, James Szymanski, Joan Uehlinger, Rona Singer Weinberg, Monika Paroder17-07-2021
Bone marrow necrosis and fat embolism syndrome in sickle cell disease: A rapidly deteriorating complication.
By Mohammad Barouqa, James Szymanski, Randin Nelson, Sebastian Jofre, Monika Paroder11-03-2021
ABO blood type association with SARS-CoV-2 infection mortality: A single-center population in New York City.
By James Szymanski, Laurel Mohrmann, Jamal Carter, Randin Nelson, Sweta Chekuri, Andrei Assa, Brian Spund, Morayma Reyes-Gil, Joan Uehlinger, Sarah W. Baron, Monika Paroder05-03-2021
Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis
By Shalom Z. Frager, James Szymanski, Jonathan M. Schwartz, Hatef Massoumi, Milan Kinkhabwala, Allan W. Wolkoff01-03-2021
Using Automated Machine Learning to Predict the Mortality of Patients With COVID-19: Prediction Model Development Study.
By Kenji Ikemura, Eran Bellin, Yukako Yagi, Henny H. Billett, Mahmoud Saada, Katelyn Simone, Lindsay Stahl, James Szymanski, D Y Goldstein, Morayma Reyes Gil26-02-2021
Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort
By Morayma Reyes Gil, Jesus D. Gonzalez-Lugo, Shafia Rahman, Mohammad Barouqa, James Szymanski, Kenji Ikemura, Yungtai Lo, Henny H. Billett23-02-2021
SARS-CoV-2 PCR cycle threshold at hospital admission associated with patient mortality.
By Jui Choudhuri, Jamal Carter, Randin Nelson, Karin A. Skalina, Marika Osterbur-Badhey, Andrew D. Johnston, Goldstein, Monika Paroder, James Szymanski31-12-2020
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.
By Henny H. Billett, Morayma Reyes-Gil, James Szymanski, Kenji Ikemura, Lindsay Stahl, Shafia Rahman, Jesus D. Gonzalez-Lugo, Margarita Kushnir, Mohammad Barouqa, Ladan Golestaneh, Eran Bellin13-11-2020
Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).
By Morayma Reyes Gil, Mohammad Barouqa, James Szymanski, Jesus D. Gonzalez-Lugo, Shafia Rahman, Henny H. Billett03-08-2020
Group O plasma as a media supplement for CAR-T cells and other adoptive T-cell therapies.
By Randin Nelson, Vicki Fellowes, Ping Jin, Hui Liu, Steven L. Highfill, Jiaqiang Ren, Willy A. Flegel, David F. Stroncek, James Szymanski13-03-2020
Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis.
By James Szymanski, Meryl Waldman, Cathy Conry-Cantilena, Kamille A. West10-12-2018
Breast pathology and mammography BI-RADS category correlation study - A single institute experience.
By Shaomin Hu, James Szymanski, Zeina Khairy, Yungtai Lo, Yanhua Wang01-08-2018
Impact of Prothrombin Complex Concentrate on Blood Use, Cost, and Outcomes in Heart Transplantation
By Ding Wen Wu, Joan Uelinger, S. Forest, James Szymanski, Kala Mohandas, Ronald Walsh, Sadiqa Karim, Etan Marks, Evan Himchak, Ritu Gupta, Daniel J. Goldstein, Y. Xia01-04-2018
Laboratory and clinical predictors of 30-day survival for patients on Extracorporeal Membrane Oxygenation (ECMO): 8-Year experience at Albert Einstein College of Medicine, Montefiore Medical Center
By Ivo M.B. Francischetti, James Szymanski, Daniel Rodriguez, Moonseong Heo, Lucia R. Wolgast01-08-2017
Onboarding for Pathology Residency Programs—The Montefiore Experience:
By Tiffany Hebert, James Szymanski, Jose G. Mantilla, Ronald Walsh, Ljiljana V. Vasovic, Jacob J. Steinberg, Michael B. Prystowsky01-01-2016